en 
Will the ABC course-correct with Williams at the helm? Now that trust in legacy media is at historical lows, the ABC’s partnership with TNI does little to assuage fears that the network has passed the point of no return.
New ABC Fact-Checkers, Same Problems? Read Journal Article
Prasad’s new framework has halted low-risk approvals unless backed by RCTs. Yes, the mRNA platform is still alive—and still fiercely protected—but reform was never going to be easy. And it was never going to come all at once.
Covid-19 Vaccine Reform Is Moving Slower Than Many Had Hoped Read Journal Article
In January 2021, in the absence of any human data in pregnancy, the CDC stated on its website that mRNA vaccines were “unlikely to pose a specific risk for people who are pregnant.” Behind the scenes however, Pfizer was scrambling to conduct a clinical trial of its vaccine in pregnant women. By February 2022, Pfizer revealed it still did “not yet have a complete data set.”
Pfizer Drip Feeds Data From its Pregnancy Trial Read Journal Article
I understand the need to protect national security, but safeguarding it must never become an excuse to silence legitimate scrutiny — or intimidate journalists whose role is to hold the powerful to account — or to punish whistleblowers exposing real wrongdoing.
Trump’s War on Leaks: Is Journalism the Next Casualty? Read Journal Article
Major international governments have signed multibillion-dollar legal contracts with drug companies in order to secure access to covid-19 vaccines. But the drug companies and governments have refused to divulge details, saying the information is “commercial in confidence.”
Why the Secrecy Over Vaccine Contracts? Read Journal Article
Unshrunk: A Story of Psychiatric Treatment Resistance is more than a memoir of Laura Delano’s journey through pain, survival, and recovery. It is a fearless, forensic examination of a psychiatric system that often harms those it is meant to help.
Unshrunk: Laura Delano’s Breakaway from Psychiatry Read Journal Article
Levi is no stranger to weighing risk. A professor at MIT with deep experience in data analytics and risk-based decision-making, he had combed through five clinical trials of RSV monoclonals, including clesrovimab and its predecessor, nirsevimab.
Retsef Levi Explains His Vote against Routine RSV Monoclonal Use in Newborns Read Journal Article
Of all the antiviral drugs for Covid-19, Pfizer’s Paxlovid has been the most successful. Not for its safety and efficacy, but for its ability to earn the company billions in profits despite being largely ineffective for most people.
Is Paxlovid a Dud? Read Journal Article
On January 3, 2024, Florida Surgeon General Joseph Ladapo called for a halt in the use of the mRNA Covid-19 vaccines after US health agencies failed to adequately address his concerns about DNA contamination in the products.
Florida Surgeon General’s Call to Halt Use of the Vaccines Sparks Debate Read Journal Article
Deutsch
Français
Italiano
Español
Português
Català
Nederlands
Dansk
Norsk bokmål
Svenska
Suomi
Eesti
Latviešu valoda
Lietuvių kalba
Polski
Čeština
Magyar
Հայերեն
ქართული
Русский
Română
Українська
Hrvatski
Slovenščina
Ελληνικά
Türkçe
日本語
한국어
简体中文
हिन्दी
Harshen Hausa
Kiswahili
አማርኛ
Yorùbá